NSEDisclosure of material issue1d ago · 21 Sept 2026, 03:08 pm
Disclosure of material issue
Anlon Healthcare Limited · AHCL
✦ AI SummaryM&A
Anlon Healthcare Limited has informed about the incorporation of its subsidiary, Anlon Healthcare Nigeria Limited, as per Regulation 30 of SEBI Listing Regulations.
Analysis Scores
Earnings Impact5/10
Growth Catalyst8/10
Governance Concern2/10
Regulatory Risk4/10
Balance Sheet Risk6/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Anlon Healthcare Limited has informed regarding Disclosure of material issue
Attachments (1)
📄pdf
Download →
ANLON2013_21092026150829_AHLIntimationforIncorporationofSubsidiarySigned.pdf
View document text
September 21, 2026
To, To,
Listing Department, The National Stock Exchange of India
BSE Limited Ltd.
Phiroze Jeejeebhoy Towers, The Listing Department
Dalal Street, Exchange Plaza,
Mumbai – 400 001 Bandra – Kurla Complex,
Ref: BSE Scrip Code: 544497 Mumbai – 400051,
NSE Scrip Code: AHCL
Sub: Intimation under Regulation 30 of Securities and Exchange Board of India
("SEBI”) (Listing Obligations and Disclosure Requirements) Regulations,
2015 ("SEBI Listing Regulations") – Incorporation of Subsidiary.
Respected Sir/Madam,
Pursuant to regulation 30 of Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") read with
SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
(“SEBI Master Circular”), we wish to inform you that “ANLON HEALTHCARE NIGERIA
LIMITED” having Registration Number “9874492” has been incorporated as a subsidiary
of the Anlon Healthcare Limited (“Company”), with effect from September 20, 2026.
The relevant details pursuant to Schedule III of the Listing Regulations and additional
details as required under the SEBI Master Circular for compliance with the provisions of
the Listing Regulations by listed entities is annexed in Annexure – A.
You are requested to take the above information on your record.
Thanking You.
For ANLON HEALTHCARE LIMITED
PUNITKUMAR RASADIA
MANAGING DIRECTOR
DIN: 06696258
ANLON HEALTHCARE LIMITED
CIN No.: L24230GJ2013PLC077543
REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot-
360005, Gujarat (INDIA)
PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in
ANNEXURE-A
Details required under Regulation 30 of SEBI LODR read with
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
Sr Particulars Description
1 Name of the target entity, country of Name of the Entity: ANLON
incorporation, details in brief such as size, HEALTHCARE NIGERIA LIMITED.
turnover etc.
Country of Incorporation: NIGERIA
Turnover: Nil as the company is the
newly incorporated company
Size of the Company: Company is
incorporated with authorized share
capital of Naira 100,000,000 and
paid up share capital of Naira
100,000,000.
2 Whether the incorporation of subsidiary Not applicable
would fall within related party
transaction(s) and whether the promoter/
promoter group/ group companies have
any interest in the entity being acquired?
If yes, nature of interest and details
thereof and whether the same is done at
“arm’s length”
3 Industry to which the entity being Pharmaceuticals, Healthcare,
incorporated belongs Personal Care, surgical implants and
medical devices
4 Objects and impact of incorporation The purpose of incorporation of this
/acquisition (including but not limited to, subsidiary is aligned with the
disclosure of reasons for acquisition of Company’s long-term growth
target entity, if its business is outside the objective. Considering this
main line of business of the listed entity) subsidiary would be manufacturing,
importing, processing, producing,
trading, packaging, selling, blending
,making of Active Pharmaceutical
Ingredients (APIs), pharmaceutical
bulk drugs, intermediates and
Finished Dosage Formulations for
human use, cosmetic and personal
care products, surgical implants and
medical devices. The Company
intends to leverage this opportunity
in order to strategically complement
and expand its existing business in
the West African market. This
subsidiary will provide access to 16
Western African Countries via its
local entity.
5 Brief details of any governmental or Not Applicable
regulatory approvals required for the
incorporation/ acquisition
ANLON HEALTHCARE LIMITED
CIN No.: L24230GJ2013PLC077543
REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot-
360005, Gujarat (INDIA)
PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in
6 Indicative time period for completion of Incorporated on September 20,
the acquisition 2026
7 Consideration - whether cash Subscription to the share capital of
consideration or share swap or any other the subsidiary is by way of banking
form and details of the same channel.
8 Cost of subscription / price at which the Equity shares subscribed by Anlon
shares are subscribed Healthcare Limited at an aggregate
of Naira. 90,000,000 (NINETY
MILLION Naira Only) to subscribe
90,000,000 (Ninety Million) equity
shares of face value Naira 1 each
(One Naira Only) of the subsidiary
company.
9 Percentage of shareholding/ control by 90% of the share capital of ANLON
the listed entity and / or number of shares HEALTHCARE NIGERIA LIMITED is
allotted held by Anlon Healthcare Limited i.e.
90,000,000 (Ninety Million) equity
shares of face value Naira 1 each
(One Naira Only) of the subsidiary
company.
10 Brief background about the entity This Company has been
acquired/ incorporated in terms of incorporated to manufacturing,
products/line of business acquired, date importing, processing, producing,
of incorporation, history of last 3 years trading, packaging, selling, blending
turnover, country in which the acquired ,making of Active Pharmaceutical
entity has presence and any other Ingredients (APIs), pharmaceutical
significant information (in brief) bulk drugs, intermediates and
Finished Dosage Formulations for
human use, cosmetic and personal
care products, surgical implants and
medical devices. In view of the
significant growth in this sector in
India as well as international
markets, the Company propose to
leverage this opportunity in order to
strategically complement and
expand our existing business in the
African pharma and healthcare
segment.
Date of Incorporation: 20/09/2026
Turnover: Not applicable (It is a
newly incorporated Company and is
yet to commence its business)
Country in which the incorporated
entity has presence: NIGERIA.
ANLON HEALTHCARE LIMITED
CIN No.: L24230GJ2013PLC077543
REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot-
360005, Gujarat (INDIA)
PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in